Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. Earnings Release 2011

May 11, 2011

7082_rns_2011-05-11_5e9c2bbd-d075-4575-acb3-7df2e9f777fc.htm

Earnings Release

Open in viewer

Opens in your device viewer

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] of transmission: 11/05/2011              Time of broadcast: 08:32 08:28:54

Reference: 2011-02-144210

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA REPORTS FIRST QUARTER 2011 RESULTS
hebengfinalwtables_isa.pdf
Attached please find the quarterly earnings press release issued today, May 11, 2011, in the U.S., and its non binding translation into Hebrew.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 13/03/2011
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: [email protected] 2